Image analysis-based identification of high risk ER-positive, HER2-negative breast cancers
- Dong Neuck Lee 1, Yao Li 2, Linnea T Olsson 3, Alina M Hamilton 4, Benjamin C Calhoun 5, Katherine A Hoadley 6, J S Marron 7, Melissa A Troester 8
- Dong Neuck Lee 1, Yao Li 2, Linnea T Olsson 3
- 1Department of Biostatistics, University of North Carolina, Chapel Hill, NC, USA.
- 2Department of Statistics and Operations Research, University of North Carolina, Chapel Hill, NC, USA.
- 3Department of Epidemiology, University of North Carolina, Chapel Hill, NC, USA.
- 4Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA.
- 5Department of Pathology and Laboratory Medicine, University of North Carolina, Chapel Hill, NC, USA.
- 6Department of Genetics, University of North Carolina, Chapel Hill, NC, USA.
- 7Department of Statistics and Operations Research, University of North Carolina, Chapel Hill, NC, USA. marron@unc.edu.
- 8Department of Epidemiology, University of North Carolina, Chapel Hill, NC, USA. troester@unc.edu.
- 0Department of Biostatistics, University of North Carolina, Chapel Hill, NC, USA.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Machine learning on H&E images can identify breast cancer subtypes (Luminal A vs. B) and predict recurrence risk, offering an alternative to genomic testing for ER+/HER2-patients.
Area Of Science
- Oncology
- Digital Pathology
- Machine Learning
Background
- Luminal A and B breast cancer subtypes are defined by PAM50 gene expression.
- These subtypes may require different treatment approaches.
- Machine learning on H&E images may identify features linked to subtype and recurrence risk.
Purpose Of The Study
- To develop and evaluate an image-based machine learning model for differentiating Luminal A and Luminal B breast cancer subtypes.
- To compare the performance of the image-based model against genomic testing (PAM50) in predicting recurrence.
- To assess the utility of image-based methods as an alternative to genomic testing.
Main Methods
- Pixel-level segmentation of H&E images (n=630 ER+/HER2-cancers) into epithelium and stroma.
- Feature extraction using convolutional neural networks and multiple instance learning.
- Training patient-level classification models for Luminal A vs. B discrimination, with and without grade adjustment.
Main Results
- The image-based protocol differentiated recurrence times with a hazard ratio (HR) of 2.81, comparable to PAM50 (HR=2.66).
- Grade adjustment improved sensitivity and specificity balance in high-grade tumors.
- Epithelium-specific and original images showed the highest accuracy.
Conclusions
- Image-based methods show promise for identifying ER+/HER2-patients who could benefit from further testing.
- These methods may help overcome low genomic testing uptake rates.
- Visual classifiers offer a potential alternative to traditional genomic subtyping.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.

